nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—HTR2C—obesity	0.102	0.406	CbGaD
Nefazodone—SLC6A4—obesity	0.0844	0.336	CbGaD
Nefazodone—HTR2A—obesity	0.0649	0.258	CbGaD
Nefazodone—SLC6A3—Diethylpropion—obesity	0.0362	0.068	CbGbCtD
Nefazodone—SLC6A3—Phendimetrazine—obesity	0.0274	0.0515	CbGbCtD
Nefazodone—SLC6A3—Sibutramine—obesity	0.0274	0.0515	CbGbCtD
Nefazodone—SLC6A2—Diethylpropion—obesity	0.0265	0.0498	CbGbCtD
Nefazodone—SLC6A4—Sibutramine—obesity	0.024	0.0451	CbGbCtD
Nefazodone—ADRA1B—Phendimetrazine—obesity	0.022	0.0413	CbGbCtD
Nefazodone—SLC6A3—Benzphetamine—obesity	0.0208	0.0391	CbGbCtD
Nefazodone—SLC6A3—Phentermine—obesity	0.0208	0.0391	CbGbCtD
Nefazodone—SLC6A2—Phendimetrazine—obesity	0.0201	0.0377	CbGbCtD
Nefazodone—SLC6A2—Sibutramine—obesity	0.0201	0.0377	CbGbCtD
Nefazodone—SLC6A3—Phenylpropanolamine—obesity	0.0198	0.0373	CbGbCtD
Nefazodone—SLC6A4—Phentermine—obesity	0.0182	0.0342	CbGbCtD
Nefazodone—SLC6A3—Bupropion—obesity	0.0177	0.0332	CbGbCtD
Nefazodone—ADRA1A—Phendimetrazine—obesity	0.0174	0.0326	CbGbCtD
Nefazodone—SLC6A3—Methamphetamine—obesity	0.0166	0.0312	CbGbCtD
Nefazodone—SLC6A2—Benzphetamine—obesity	0.0152	0.0286	CbGbCtD
Nefazodone—SLC6A2—Phentermine—obesity	0.0152	0.0286	CbGbCtD
Nefazodone—SLC6A4—Methamphetamine—obesity	0.0145	0.0273	CbGbCtD
Nefazodone—SLC6A2—Phenylpropanolamine—obesity	0.0145	0.0273	CbGbCtD
Nefazodone—ADRA2A—Benzphetamine—obesity	0.0137	0.0258	CbGbCtD
Nefazodone—ADRA1A—Benzphetamine—obesity	0.0132	0.0247	CbGbCtD
Nefazodone—ADRA2A—Phenylpropanolamine—obesity	0.0131	0.0246	CbGbCtD
Nefazodone—SLC6A2—Bupropion—obesity	0.0129	0.0243	CbGbCtD
Nefazodone—ADRA1A—Phenylpropanolamine—obesity	0.0125	0.0236	CbGbCtD
Nefazodone—SLC6A2—Methamphetamine—obesity	0.0122	0.0229	CbGbCtD
Nefazodone—ADRA2A—Methamphetamine—obesity	0.011	0.0206	CbGbCtD
Nefazodone—CYP3A7—Cimetidine—obesity	0.00619	0.0116	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00619	0.0116	CbGbCtD
Nefazodone—CYP3A5—Cimetidine—obesity	0.00464	0.00872	CbGbCtD
Nefazodone—CYP2D6—Phentermine—obesity	0.00456	0.00857	CbGbCtD
Nefazodone—CYP2D6—Bupropion—obesity	0.00388	0.00729	CbGbCtD
Nefazodone—CYP3A4—Sibutramine—obesity	0.00383	0.00719	CbGbCtD
Nefazodone—CYP2D6—Methamphetamine—obesity	0.00365	0.00685	CbGbCtD
Nefazodone—ABCB1—Cimetidine—obesity	0.00302	0.00568	CbGbCtD
Nefazodone—CYP3A4—Benzphetamine—obesity	0.0029	0.00545	CbGbCtD
Nefazodone—CYP2D6—Cimetidine—obesity	0.00285	0.00535	CbGbCtD
Nefazodone—CYP3A4—Bupropion—obesity	0.00247	0.00463	CbGbCtD
Nefazodone—SLC6A2—sympathetic nervous system—obesity	0.00223	0.106	CbGeAlD
Nefazodone—CYP3A4—Orlistat—obesity	0.00201	0.00378	CbGbCtD
Nefazodone—CYP3A4—Cimetidine—obesity	0.00181	0.0034	CbGbCtD
Nefazodone—SLC6A2—autonomic nervous system—obesity	0.0015	0.0713	CbGeAlD
Nefazodone—HTR2A—sympathetic nervous system—obesity	0.00134	0.0637	CbGeAlD
Nefazodone—HTR2A—vagus nerve—obesity	0.0013	0.0617	CbGeAlD
Nefazodone—CYP3A4—Topiramate—obesity	0.00119	0.00223	CbGbCtD
Nefazodone—HTR2A—autonomic nervous system—obesity	0.000902	0.0428	CbGeAlD
Nefazodone—SLC6A3—hindbrain—obesity	0.000784	0.0372	CbGeAlD
Nefazodone—SLC6A4—hindbrain—obesity	0.000718	0.0341	CbGeAlD
Nefazodone—HTR1A—hindbrain—obesity	0.000638	0.0303	CbGeAlD
Nefazodone—ADRA1A—hindbrain—obesity	0.000588	0.0279	CbGeAlD
Nefazodone—SLC6A3—respiratory system—obesity	0.000479	0.0227	CbGeAlD
Nefazodone—SLC6A4—respiratory system—obesity	0.000439	0.0208	CbGeAlD
Nefazodone—CYP3A7—endocrine gland—obesity	0.000427	0.0203	CbGeAlD
Nefazodone—SLC6A2—respiratory system—obesity	0.000386	0.0183	CbGeAlD
Nefazodone—CYP3A7—liver—obesity	0.000385	0.0183	CbGeAlD
Nefazodone—HTR2A—hindbrain—obesity	0.00038	0.018	CbGeAlD
Nefazodone—CYP2D6—hindbrain—obesity	0.000346	0.0164	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—liver—obesity	0.000328	0.0156	CbGeAlD
Nefazodone—CYP3A5—islet of Langerhans—obesity	0.000303	0.0144	CbGeAlD
Nefazodone—HTR1A—cardiovascular system—obesity	0.000298	0.0142	CbGeAlD
Nefazodone—ADRA2A—islet of Langerhans—obesity	0.000289	0.0137	CbGeAlD
Nefazodone—CYP3A5—respiratory system—obesity	0.000286	0.0136	CbGeAlD
Nefazodone—SLC6A4—digestive system—obesity	0.000279	0.0132	CbGeAlD
Nefazodone—ADRA1A—cardiovascular system—obesity	0.000275	0.0131	CbGeAlD
Nefazodone—ADRA1A—adipose tissue—obesity	0.000242	0.0115	CbGeAlD
Nefazodone—HTR1A—adrenal gland—obesity	0.000236	0.0112	CbGeAlD
Nefazodone—SLC6A2—adrenal gland—obesity	0.000234	0.0111	CbGeAlD
Nefazodone—HTR2A—respiratory system—obesity	0.000232	0.011	CbGeAlD
Nefazodone—SLC6A4—endocrine gland—obesity	0.00023	0.0109	CbGeAlD
Nefazodone—ADRA1A—adrenal gland—obesity	0.000218	0.0103	CbGeAlD
Nefazodone—HTR1A—endocrine gland—obesity	0.000205	0.00971	CbGeAlD
Nefazodone—SLC6A2—endocrine gland—obesity	0.000203	0.00963	CbGeAlD
Nefazodone—CYP3A5—adipose tissue—obesity	0.000193	0.00918	CbGeAlD
Nefazodone—ADRA1A—endocrine gland—obesity	0.000189	0.00895	CbGeAlD
Nefazodone—ADRA2A—pituitary gland—obesity	0.000185	0.00879	CbGeAlD
Nefazodone—ADRA2A—adipose tissue—obesity	0.000184	0.00875	CbGeAlD
Nefazodone—CYP3A5—digestive system—obesity	0.000182	0.00864	CbGeAlD
Nefazodone—HTR2A—cardiovascular system—obesity	0.000178	0.00844	CbGeAlD
Nefazodone—ADRA1A—liver—obesity	0.00017	0.00807	CbGeAlD
Nefazodone—ADRA2A—adrenal gland—obesity	0.000165	0.00785	CbGeAlD
Nefazodone—ABCB1—islet of Langerhans—obesity	0.000161	0.00765	CbGeAlD
Nefazodone—Acetophenazine—DRD1—obesity	0.000159	0.0568	CrCbGaD
Nefazodone—HTR2A—pituitary gland—obesity	0.000157	0.00747	CbGeAlD
Nefazodone—ABCB1—respiratory system—obesity	0.000152	0.00722	CbGeAlD
Nefazodone—CYP3A5—endocrine gland—obesity	0.00015	0.00714	CbGeAlD
Nefazodone—HTR2A—digestive system—obesity	0.000148	0.00701	CbGeAlD
Nefazodone—ADRA2A—endocrine gland—obesity	0.000143	0.00681	CbGeAlD
Nefazodone—HTR2A—adrenal gland—obesity	0.000141	0.00668	CbGeAlD
Nefazodone—CYP3A4—digestive system—obesity	0.000137	0.00649	CbGeAlD
Nefazodone—CYP3A5—liver—obesity	0.000136	0.00644	CbGeAlD
Nefazodone—CYP2D6—digestive system—obesity	0.000134	0.00638	CbGeAlD
Nefazodone—ABCB1—adrenal cortex—obesity	0.000128	0.00606	CbGeAlD
Nefazodone—HTR2A—endocrine gland—obesity	0.000122	0.00579	CbGeAlD
Nefazodone—ABCB1—cardiovascular system—obesity	0.000116	0.00553	CbGeAlD
Nefazodone—CYP3A4—endocrine gland—obesity	0.000113	0.00536	CbGeAlD
Nefazodone—Acetophenazine—DRD2—obesity	0.000112	0.04	CrCbGaD
Nefazodone—CYP2D6—endocrine gland—obesity	0.000111	0.00527	CbGeAlD
Nefazodone—Aripiprazole—DRD4—obesity	0.00011	0.0393	CrCbGaD
Nefazodone—HTR2A—liver—obesity	0.00011	0.00522	CbGeAlD
Nefazodone—Thioproperazine—SLC22A1—obesity	0.000108	0.0385	CrCbGaD
Nefazodone—ABCB1—pituitary gland—obesity	0.000103	0.0049	CbGeAlD
Nefazodone—ABCB1—adipose tissue—obesity	0.000103	0.00488	CbGeAlD
Nefazodone—CYP3A4—liver—obesity	0.000102	0.00483	CbGeAlD
Nefazodone—Zuclopenthixol—DRD1—obesity	0.000101	0.0359	CrCbGaD
Nefazodone—CYP2D6—liver—obesity	0.0001	0.00476	CbGeAlD
Nefazodone—Aripiprazole—HTR1B—obesity	9.77e-05	0.0349	CrCbGaD
Nefazodone—ABCB1—digestive system—obesity	9.67e-05	0.00459	CbGeAlD
Nefazodone—Aripiprazole—DRD1—obesity	9.31e-05	0.0332	CrCbGaD
Nefazodone—ABCB1—adrenal gland—obesity	9.21e-05	0.00437	CbGeAlD
Nefazodone—Thioproperazine—DRD1—obesity	8.83e-05	0.0315	CrCbGaD
Nefazodone—Aripiprazole—ADRB1—obesity	8.64e-05	0.0308	CrCbGaD
Nefazodone—Domperidone—DRD2—obesity	8.5e-05	0.0303	CrCbGaD
Nefazodone—Agitation—Sibutramine—obesity	8e-05	0.000666	CcSEcCtD
Nefazodone—ABCB1—endocrine gland—obesity	7.99e-05	0.00379	CbGeAlD
Nefazodone—Aripiprazole—HTR2C—obesity	7.97e-05	0.0284	CrCbGaD
Nefazodone—Disturbance in sexual arousal—Topiramate—obesity	7.96e-05	0.000663	CcSEcCtD
Nefazodone—Angioedema—Sibutramine—obesity	7.95e-05	0.000662	CcSEcCtD
Nefazodone—Palpitations—Orlistat—obesity	7.95e-05	0.000662	CcSEcCtD
Nefazodone—Trazodone—HTR2C—obesity	7.93e-05	0.0283	CrCbGaD
Nefazodone—Migraine—Topiramate—obesity	7.9e-05	0.000658	CcSEcCtD
Nefazodone—Affect lability—Topiramate—obesity	7.9e-05	0.000658	CcSEcCtD
Nefazodone—Nausea—Cimetidine—obesity	7.89e-05	0.000657	CcSEcCtD
Nefazodone—Malaise—Sibutramine—obesity	7.85e-05	0.000653	CcSEcCtD
Nefazodone—Cough—Orlistat—obesity	7.85e-05	0.000653	CcSEcCtD
Nefazodone—Chills—Bupropion—obesity	7.82e-05	0.000651	CcSEcCtD
Nefazodone—Vertigo—Sibutramine—obesity	7.82e-05	0.000651	CcSEcCtD
Nefazodone—Syncope—Sibutramine—obesity	7.8e-05	0.00065	CcSEcCtD
Nefazodone—Convulsion—Orlistat—obesity	7.79e-05	0.000649	CcSEcCtD
Nefazodone—Leukopenia—Sibutramine—obesity	7.79e-05	0.000649	CcSEcCtD
Nefazodone—Face oedema—Topiramate—obesity	7.75e-05	0.000645	CcSEcCtD
Nefazodone—Alopecia—Bupropion—obesity	7.7e-05	0.000641	CcSEcCtD
Nefazodone—Palpitations—Sibutramine—obesity	7.69e-05	0.00064	CcSEcCtD
Nefazodone—Myalgia—Orlistat—obesity	7.65e-05	0.000637	CcSEcCtD
Nefazodone—Chest pain—Orlistat—obesity	7.65e-05	0.000637	CcSEcCtD
Nefazodone—Loss of consciousness—Sibutramine—obesity	7.65e-05	0.000637	CcSEcCtD
Nefazodone—Urinary retention—Topiramate—obesity	7.63e-05	0.000635	CcSEcCtD
Nefazodone—Anxiety—Orlistat—obesity	7.63e-05	0.000635	CcSEcCtD
Nefazodone—Mood swings—Topiramate—obesity	7.6e-05	0.000633	CcSEcCtD
Nefazodone—Cough—Sibutramine—obesity	7.59e-05	0.000632	CcSEcCtD
Nefazodone—Discomfort—Orlistat—obesity	7.56e-05	0.00063	CcSEcCtD
Nefazodone—Ataxia—Topiramate—obesity	7.55e-05	0.000628	CcSEcCtD
Nefazodone—Convulsion—Sibutramine—obesity	7.54e-05	0.000628	CcSEcCtD
Nefazodone—Hypertension—Sibutramine—obesity	7.51e-05	0.000626	CcSEcCtD
Nefazodone—Fluphenazine—DRD1—obesity	7.51e-05	0.0268	CrCbGaD
Nefazodone—Dry mouth—Orlistat—obesity	7.49e-05	0.000623	CcSEcCtD
Nefazodone—Flatulence—Bupropion—obesity	7.47e-05	0.000622	CcSEcCtD
Nefazodone—Dehydration—Topiramate—obesity	7.46e-05	0.000621	CcSEcCtD
Nefazodone—Dysgeusia—Bupropion—obesity	7.43e-05	0.000619	CcSEcCtD
Nefazodone—Liver function test abnormal—Topiramate—obesity	7.41e-05	0.000617	CcSEcCtD
Nefazodone—Myalgia—Sibutramine—obesity	7.41e-05	0.000617	CcSEcCtD
Nefazodone—Chest pain—Sibutramine—obesity	7.41e-05	0.000617	CcSEcCtD
Nefazodone—Arthralgia—Sibutramine—obesity	7.41e-05	0.000617	CcSEcCtD
Nefazodone—Anxiety—Sibutramine—obesity	7.38e-05	0.000615	CcSEcCtD
Nefazodone—Oedema—Orlistat—obesity	7.34e-05	0.000611	CcSEcCtD
Nefazodone—Anaphylactic shock—Orlistat—obesity	7.34e-05	0.000611	CcSEcCtD
Nefazodone—Back pain—Bupropion—obesity	7.34e-05	0.000611	CcSEcCtD
Nefazodone—Orthostatic hypotension—Topiramate—obesity	7.33e-05	0.00061	CcSEcCtD
Nefazodone—Discomfort—Sibutramine—obesity	7.32e-05	0.000609	CcSEcCtD
Nefazodone—Muscle spasms—Bupropion—obesity	7.29e-05	0.000607	CcSEcCtD
Nefazodone—Infection—Orlistat—obesity	7.29e-05	0.000607	CcSEcCtD
Nefazodone—Dry mouth—Sibutramine—obesity	7.24e-05	0.000603	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Topiramate—obesity	7.23e-05	0.000602	CcSEcCtD
Nefazodone—ABCB1—liver—obesity	7.2e-05	0.00342	CbGeAlD
Nefazodone—Confusional state—Sibutramine—obesity	7.16e-05	0.000596	CcSEcCtD
Nefazodone—Vision blurred—Bupropion—obesity	7.15e-05	0.000595	CcSEcCtD
Nefazodone—Tremor—Bupropion—obesity	7.11e-05	0.000592	CcSEcCtD
Nefazodone—Gastritis—Topiramate—obesity	7.1e-05	0.000591	CcSEcCtD
Nefazodone—Zuclopenthixol—DRD2—obesity	7.1e-05	0.0253	CrCbGaD
Nefazodone—Oedema—Sibutramine—obesity	7.1e-05	0.000591	CcSEcCtD
Nefazodone—Anaphylactic shock—Sibutramine—obesity	7.1e-05	0.000591	CcSEcCtD
Nefazodone—Prochlorperazine—HTR2C—obesity	7.1e-05	0.0253	CrCbGaD
Nefazodone—Hyperhidrosis—Orlistat—obesity	7.09e-05	0.000591	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Topiramate—obesity	7.08e-05	0.000589	CcSEcCtD
Nefazodone—Infection—Sibutramine—obesity	7.05e-05	0.000587	CcSEcCtD
Nefazodone—Ill-defined disorder—Bupropion—obesity	7.04e-05	0.000586	CcSEcCtD
Nefazodone—Anaemia—Bupropion—obesity	7.01e-05	0.000584	CcSEcCtD
Nefazodone—Shock—Sibutramine—obesity	6.99e-05	0.000582	CcSEcCtD
Nefazodone—Abdominal distension—Topiramate—obesity	6.98e-05	0.000581	CcSEcCtD
Nefazodone—Agitation—Bupropion—obesity	6.97e-05	0.00058	CcSEcCtD
Nefazodone—Thrombocytopenia—Sibutramine—obesity	6.95e-05	0.000579	CcSEcCtD
Nefazodone—Dysphagia—Topiramate—obesity	6.94e-05	0.000578	CcSEcCtD
Nefazodone—Asthma—Topiramate—obesity	6.94e-05	0.000578	CcSEcCtD
Nefazodone—Angioedema—Bupropion—obesity	6.93e-05	0.000577	CcSEcCtD
Nefazodone—Tachycardia—Sibutramine—obesity	6.93e-05	0.000577	CcSEcCtD
Nefazodone—Quetiapine—DRD4—obesity	6.88e-05	0.0245	CrCbGaD
Nefazodone—Hyperhidrosis—Sibutramine—obesity	6.87e-05	0.000572	CcSEcCtD
Nefazodone—Malaise—Bupropion—obesity	6.84e-05	0.00057	CcSEcCtD
Nefazodone—Vertigo—Bupropion—obesity	6.82e-05	0.000568	CcSEcCtD
Nefazodone—Syncope—Bupropion—obesity	6.8e-05	0.000566	CcSEcCtD
Nefazodone—Leukopenia—Bupropion—obesity	6.79e-05	0.000565	CcSEcCtD
Nefazodone—Anorexia—Sibutramine—obesity	6.77e-05	0.000564	CcSEcCtD
Nefazodone—Angina pectoris—Topiramate—obesity	6.76e-05	0.000563	CcSEcCtD
Nefazodone—Palpitations—Bupropion—obesity	6.7e-05	0.000558	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Orlistat—obesity	6.69e-05	0.000557	CcSEcCtD
Nefazodone—Bronchitis—Topiramate—obesity	6.67e-05	0.000555	CcSEcCtD
Nefazodone—Loss of consciousness—Bupropion—obesity	6.67e-05	0.000555	CcSEcCtD
Nefazodone—Insomnia—Orlistat—obesity	6.64e-05	0.000553	CcSEcCtD
Nefazodone—Hypotension—Sibutramine—obesity	6.64e-05	0.000553	CcSEcCtD
Nefazodone—Cough—Bupropion—obesity	6.62e-05	0.000551	CcSEcCtD
Nefazodone—Aripiprazole—SLC6A4—obesity	6.6e-05	0.0236	CrCbGaD
Nefazodone—Paraesthesia—Orlistat—obesity	6.59e-05	0.000549	CcSEcCtD
Nefazodone—Convulsion—Bupropion—obesity	6.57e-05	0.000547	CcSEcCtD
Nefazodone—Trazodone—SLC6A4—obesity	6.57e-05	0.0234	CrCbGaD
Nefazodone—Aripiprazole—DRD2—obesity	6.56e-05	0.0234	CrCbGaD
Nefazodone—Hypertension—Bupropion—obesity	6.55e-05	0.000545	CcSEcCtD
Nefazodone—Dysuria—Topiramate—obesity	6.49e-05	0.00054	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Sibutramine—obesity	6.47e-05	0.000539	CcSEcCtD
Nefazodone—Dyspepsia—Orlistat—obesity	6.46e-05	0.000538	CcSEcCtD
Nefazodone—Myalgia—Bupropion—obesity	6.46e-05	0.000538	CcSEcCtD
Nefazodone—Arthralgia—Bupropion—obesity	6.46e-05	0.000538	CcSEcCtD
Nefazodone—Chest pain—Bupropion—obesity	6.46e-05	0.000538	CcSEcCtD
Nefazodone—Anxiety—Bupropion—obesity	6.44e-05	0.000536	CcSEcCtD
Nefazodone—Insomnia—Sibutramine—obesity	6.42e-05	0.000535	CcSEcCtD
Nefazodone—Fluphenazine—HTR2C—obesity	6.42e-05	0.0229	CrCbGaD
Nefazodone—Pollakiuria—Topiramate—obesity	6.41e-05	0.000534	CcSEcCtD
Nefazodone—Erectile dysfunction—Topiramate—obesity	6.39e-05	0.000532	CcSEcCtD
Nefazodone—Discomfort—Bupropion—obesity	6.38e-05	0.000531	CcSEcCtD
Nefazodone—Decreased appetite—Orlistat—obesity	6.38e-05	0.000531	CcSEcCtD
Nefazodone—Paraesthesia—Sibutramine—obesity	6.38e-05	0.000531	CcSEcCtD
Nefazodone—Dyspnoea—Sibutramine—obesity	6.33e-05	0.000527	CcSEcCtD
Nefazodone—Photosensitivity reaction—Topiramate—obesity	6.33e-05	0.000527	CcSEcCtD
Nefazodone—Dry mouth—Bupropion—obesity	6.32e-05	0.000526	CcSEcCtD
Nefazodone—Somnolence—Sibutramine—obesity	6.31e-05	0.000526	CcSEcCtD
Nefazodone—Weight increased—Topiramate—obesity	6.31e-05	0.000526	CcSEcCtD
Nefazodone—Weight decreased—Topiramate—obesity	6.27e-05	0.000523	CcSEcCtD
Nefazodone—Pain—Orlistat—obesity	6.27e-05	0.000523	CcSEcCtD
Nefazodone—Dyspepsia—Sibutramine—obesity	6.25e-05	0.000521	CcSEcCtD
Nefazodone—Confusional state—Bupropion—obesity	6.24e-05	0.00052	CcSEcCtD
Nefazodone—Thioproperazine—DRD2—obesity	6.22e-05	0.0222	CrCbGaD
Nefazodone—Pneumonia—Topiramate—obesity	6.22e-05	0.000518	CcSEcCtD
Nefazodone—Anaphylactic shock—Bupropion—obesity	6.19e-05	0.000516	CcSEcCtD
Nefazodone—Oedema—Bupropion—obesity	6.19e-05	0.000516	CcSEcCtD
Nefazodone—Decreased appetite—Sibutramine—obesity	6.17e-05	0.000514	CcSEcCtD
Nefazodone—Infection—Bupropion—obesity	6.15e-05	0.000512	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Topiramate—obesity	6.13e-05	0.000511	CcSEcCtD
Nefazodone—Quetiapine—HTR1B—obesity	6.11e-05	0.0218	CrCbGaD
Nefazodone—Shock—Bupropion—obesity	6.09e-05	0.000507	CcSEcCtD
Nefazodone—Constipation—Sibutramine—obesity	6.07e-05	0.000506	CcSEcCtD
Nefazodone—Pain—Sibutramine—obesity	6.07e-05	0.000506	CcSEcCtD
Nefazodone—Thrombocytopenia—Bupropion—obesity	6.06e-05	0.000505	CcSEcCtD
Nefazodone—Feeling abnormal—Orlistat—obesity	6.05e-05	0.000504	CcSEcCtD
Nefazodone—Tachycardia—Bupropion—obesity	6.04e-05	0.000503	CcSEcCtD
Nefazodone—Stomatitis—Topiramate—obesity	6.03e-05	0.000502	CcSEcCtD
Nefazodone—Conjunctivitis—Topiramate—obesity	6.01e-05	0.000501	CcSEcCtD
Nefazodone—Urinary tract infection—Topiramate—obesity	6.01e-05	0.000501	CcSEcCtD
Nefazodone—Gastrointestinal pain—Orlistat—obesity	6e-05	0.0005	CcSEcCtD
Nefazodone—Hyperhidrosis—Bupropion—obesity	5.98e-05	0.000498	CcSEcCtD
Nefazodone—Perphenazine—DRD1—obesity	5.93e-05	0.0212	CrCbGaD
Nefazodone—Anorexia—Bupropion—obesity	5.9e-05	0.000491	CcSEcCtD
Nefazodone—Haematuria—Topiramate—obesity	5.9e-05	0.000491	CcSEcCtD
Nefazodone—Feeling abnormal—Sibutramine—obesity	5.85e-05	0.000487	CcSEcCtD
Nefazodone—Prochlorperazine—DRD2—obesity	5.85e-05	0.0209	CrCbGaD
Nefazodone—Epistaxis—Topiramate—obesity	5.83e-05	0.000486	CcSEcCtD
Nefazodone—Urticaria—Orlistat—obesity	5.83e-05	0.000485	CcSEcCtD
Nefazodone—Quetiapine—DRD1—obesity	5.82e-05	0.0208	CrCbGaD
Nefazodone—Gastrointestinal pain—Sibutramine—obesity	5.81e-05	0.000484	CcSEcCtD
Nefazodone—Sinusitis—Topiramate—obesity	5.8e-05	0.000483	CcSEcCtD
Nefazodone—Abdominal pain—Orlistat—obesity	5.8e-05	0.000483	CcSEcCtD
Nefazodone—Body temperature increased—Orlistat—obesity	5.8e-05	0.000483	CcSEcCtD
Nefazodone—Hypotension—Bupropion—obesity	5.78e-05	0.000482	CcSEcCtD
Nefazodone—Bradycardia—Topiramate—obesity	5.65e-05	0.000471	CcSEcCtD
Nefazodone—Urticaria—Sibutramine—obesity	5.64e-05	0.00047	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Bupropion—obesity	5.64e-05	0.00047	CcSEcCtD
Nefazodone—Body temperature increased—Sibutramine—obesity	5.61e-05	0.000467	CcSEcCtD
Nefazodone—Abdominal pain—Sibutramine—obesity	5.61e-05	0.000467	CcSEcCtD
Nefazodone—Insomnia—Bupropion—obesity	5.6e-05	0.000466	CcSEcCtD
Nefazodone—Haemoglobin—Topiramate—obesity	5.58e-05	0.000465	CcSEcCtD
Nefazodone—Rhinitis—Topiramate—obesity	5.57e-05	0.000463	CcSEcCtD
Nefazodone—Paraesthesia—Bupropion—obesity	5.56e-05	0.000463	CcSEcCtD
Nefazodone—Hepatitis—Topiramate—obesity	5.55e-05	0.000462	CcSEcCtD
Nefazodone—Haemorrhage—Topiramate—obesity	5.55e-05	0.000462	CcSEcCtD
Nefazodone—Hypoaesthesia—Topiramate—obesity	5.52e-05	0.00046	CcSEcCtD
Nefazodone—Hallucination—Topiramate—obesity	5.52e-05	0.00046	CcSEcCtD
Nefazodone—Dyspnoea—Bupropion—obesity	5.52e-05	0.00046	CcSEcCtD
Nefazodone—Pharyngitis—Topiramate—obesity	5.51e-05	0.000459	CcSEcCtD
Nefazodone—Somnolence—Bupropion—obesity	5.5e-05	0.000458	CcSEcCtD
Nefazodone—Zuclopenthixol—HTR2A—obesity	5.49e-05	0.0196	CrCbGaD
Nefazodone—Oedema peripheral—Topiramate—obesity	5.47e-05	0.000455	CcSEcCtD
Nefazodone—Dyspepsia—Bupropion—obesity	5.45e-05	0.000454	CcSEcCtD
Nefazodone—Hypersensitivity—Orlistat—obesity	5.41e-05	0.00045	CcSEcCtD
Nefazodone—Decreased appetite—Bupropion—obesity	5.38e-05	0.000448	CcSEcCtD
Nefazodone—Visual impairment—Topiramate—obesity	5.35e-05	0.000446	CcSEcCtD
Nefazodone—Constipation—Bupropion—obesity	5.29e-05	0.000441	CcSEcCtD
Nefazodone—Pain—Bupropion—obesity	5.29e-05	0.000441	CcSEcCtD
Nefazodone—Fluphenazine—DRD2—obesity	5.29e-05	0.0189	CrCbGaD
Nefazodone—Asthenia—Orlistat—obesity	5.26e-05	0.000438	CcSEcCtD
Nefazodone—Erythema multiforme—Topiramate—obesity	5.25e-05	0.000437	CcSEcCtD
Nefazodone—Hypersensitivity—Sibutramine—obesity	5.23e-05	0.000436	CcSEcCtD
Nefazodone—Pruritus—Orlistat—obesity	5.19e-05	0.000432	CcSEcCtD
Nefazodone—Tinnitus—Topiramate—obesity	5.18e-05	0.000431	CcSEcCtD
Nefazodone—Flushing—Topiramate—obesity	5.15e-05	0.000429	CcSEcCtD
Nefazodone—Trifluoperazine—HTR2C—obesity	5.13e-05	0.0183	CrCbGaD
Nefazodone—Feeling abnormal—Bupropion—obesity	5.1e-05	0.000425	CcSEcCtD
Nefazodone—Asthenia—Sibutramine—obesity	5.1e-05	0.000424	CcSEcCtD
Nefazodone—Fluphenazine—CYP2E1—obesity	5.09e-05	0.0182	CrCbGaD
Nefazodone—Perphenazine—HTR2C—obesity	5.08e-05	0.0181	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—obesity	5.07e-05	0.0181	CrCbGaD
Nefazodone—Gastrointestinal pain—Bupropion—obesity	5.06e-05	0.000422	CcSEcCtD
Nefazodone—Trazodone—HTR2A—obesity	5.05e-05	0.018	CrCbGaD
Nefazodone—Pruritus—Sibutramine—obesity	5.02e-05	0.000418	CcSEcCtD
Nefazodone—Diarrhoea—Orlistat—obesity	5.02e-05	0.000418	CcSEcCtD
Nefazodone—Chills—Topiramate—obesity	4.98e-05	0.000415	CcSEcCtD
Nefazodone—Quetiapine—HTR2C—obesity	4.98e-05	0.0178	CrCbGaD
Nefazodone—Urticaria—Bupropion—obesity	4.92e-05	0.00041	CcSEcCtD
Nefazodone—Alopecia—Topiramate—obesity	4.91e-05	0.000409	CcSEcCtD
Nefazodone—Body temperature increased—Bupropion—obesity	4.89e-05	0.000408	CcSEcCtD
Nefazodone—Abdominal pain—Bupropion—obesity	4.89e-05	0.000408	CcSEcCtD
Nefazodone—Diarrhoea—Sibutramine—obesity	4.86e-05	0.000405	CcSEcCtD
Nefazodone—Dizziness—Orlistat—obesity	4.85e-05	0.000404	CcSEcCtD
Nefazodone—Thioproperazine—HTR2A—obesity	4.81e-05	0.0172	CrCbGaD
Nefazodone—Flatulence—Topiramate—obesity	4.76e-05	0.000397	CcSEcCtD
Nefazodone—Dysgeusia—Topiramate—obesity	4.73e-05	0.000394	CcSEcCtD
Nefazodone—Dizziness—Sibutramine—obesity	4.7e-05	0.000391	CcSEcCtD
Nefazodone—Back pain—Topiramate—obesity	4.67e-05	0.000389	CcSEcCtD
Nefazodone—Vomiting—Orlistat—obesity	4.67e-05	0.000389	CcSEcCtD
Nefazodone—Muscle spasms—Topiramate—obesity	4.65e-05	0.000387	CcSEcCtD
Nefazodone—Rash—Orlistat—obesity	4.63e-05	0.000385	CcSEcCtD
Nefazodone—Dermatitis—Orlistat—obesity	4.62e-05	0.000385	CcSEcCtD
Nefazodone—Headache—Orlistat—obesity	4.6e-05	0.000383	CcSEcCtD
Nefazodone—Hypersensitivity—Bupropion—obesity	4.56e-05	0.00038	CcSEcCtD
Nefazodone—Vision blurred—Topiramate—obesity	4.55e-05	0.000379	CcSEcCtD
Nefazodone—Tremor—Topiramate—obesity	4.53e-05	0.000377	CcSEcCtD
Nefazodone—Vomiting—Sibutramine—obesity	4.52e-05	0.000376	CcSEcCtD
Nefazodone—Ill-defined disorder—Topiramate—obesity	4.48e-05	0.000373	CcSEcCtD
Nefazodone—Rash—Sibutramine—obesity	4.48e-05	0.000373	CcSEcCtD
Nefazodone—Dermatitis—Sibutramine—obesity	4.47e-05	0.000373	CcSEcCtD
Nefazodone—Anaemia—Topiramate—obesity	4.47e-05	0.000372	CcSEcCtD
Nefazodone—Headache—Sibutramine—obesity	4.45e-05	0.00037	CcSEcCtD
Nefazodone—Asthenia—Bupropion—obesity	4.44e-05	0.00037	CcSEcCtD
Nefazodone—Agitation—Topiramate—obesity	4.44e-05	0.00037	CcSEcCtD
Nefazodone—Pruritus—Bupropion—obesity	4.38e-05	0.000365	CcSEcCtD
Nefazodone—Nausea—Orlistat—obesity	4.36e-05	0.000363	CcSEcCtD
Nefazodone—Malaise—Topiramate—obesity	4.36e-05	0.000363	CcSEcCtD
Nefazodone—Vertigo—Topiramate—obesity	4.34e-05	0.000362	CcSEcCtD
Nefazodone—Syncope—Topiramate—obesity	4.33e-05	0.000361	CcSEcCtD
Nefazodone—Leukopenia—Topiramate—obesity	4.33e-05	0.00036	CcSEcCtD
Nefazodone—Palpitations—Topiramate—obesity	4.27e-05	0.000356	CcSEcCtD
Nefazodone—Loss of consciousness—Topiramate—obesity	4.25e-05	0.000354	CcSEcCtD
Nefazodone—Diarrhoea—Bupropion—obesity	4.24e-05	0.000353	CcSEcCtD
Nefazodone—Trifluoperazine—DRD2—obesity	4.23e-05	0.0151	CrCbGaD
Nefazodone—Nausea—Sibutramine—obesity	4.22e-05	0.000351	CcSEcCtD
Nefazodone—Cough—Topiramate—obesity	4.22e-05	0.000351	CcSEcCtD
Nefazodone—Convulsion—Topiramate—obesity	4.19e-05	0.000349	CcSEcCtD
Nefazodone—Perphenazine—DRD2—obesity	4.18e-05	0.0149	CrCbGaD
Nefazodone—Hypertension—Topiramate—obesity	4.17e-05	0.000347	CcSEcCtD
Nefazodone—Chest pain—Topiramate—obesity	4.11e-05	0.000343	CcSEcCtD
Nefazodone—Arthralgia—Topiramate—obesity	4.11e-05	0.000343	CcSEcCtD
Nefazodone—Myalgia—Topiramate—obesity	4.11e-05	0.000343	CcSEcCtD
Nefazodone—Quetiapine—DRD2—obesity	4.1e-05	0.0146	CrCbGaD
Nefazodone—Anxiety—Topiramate—obesity	4.1e-05	0.000341	CcSEcCtD
Nefazodone—Dizziness—Bupropion—obesity	4.09e-05	0.000341	CcSEcCtD
Nefazodone—Fluphenazine—HTR2A—obesity	4.09e-05	0.0146	CrCbGaD
Nefazodone—Discomfort—Topiramate—obesity	4.07e-05	0.000339	CcSEcCtD
Nefazodone—Dry mouth—Topiramate—obesity	4.02e-05	0.000335	CcSEcCtD
Nefazodone—Confusional state—Topiramate—obesity	3.98e-05	0.000331	CcSEcCtD
Nefazodone—Oedema—Topiramate—obesity	3.94e-05	0.000328	CcSEcCtD
Nefazodone—Vomiting—Bupropion—obesity	3.94e-05	0.000328	CcSEcCtD
Nefazodone—Infection—Topiramate—obesity	3.92e-05	0.000326	CcSEcCtD
Nefazodone—Rash—Bupropion—obesity	3.9e-05	0.000325	CcSEcCtD
Nefazodone—Dermatitis—Bupropion—obesity	3.9e-05	0.000325	CcSEcCtD
Nefazodone—Shock—Topiramate—obesity	3.88e-05	0.000323	CcSEcCtD
Nefazodone—Headache—Bupropion—obesity	3.88e-05	0.000323	CcSEcCtD
Nefazodone—Thrombocytopenia—Topiramate—obesity	3.86e-05	0.000322	CcSEcCtD
Nefazodone—Tachycardia—Topiramate—obesity	3.85e-05	0.000321	CcSEcCtD
Nefazodone—Hyperhidrosis—Topiramate—obesity	3.81e-05	0.000318	CcSEcCtD
Nefazodone—Anorexia—Topiramate—obesity	3.76e-05	0.000313	CcSEcCtD
Nefazodone—Hypotension—Topiramate—obesity	3.69e-05	0.000307	CcSEcCtD
Nefazodone—Nausea—Bupropion—obesity	3.68e-05	0.000306	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Topiramate—obesity	3.59e-05	0.000299	CcSEcCtD
Nefazodone—Insomnia—Topiramate—obesity	3.57e-05	0.000297	CcSEcCtD
Nefazodone—Paraesthesia—Topiramate—obesity	3.54e-05	0.000295	CcSEcCtD
Nefazodone—Dyspnoea—Topiramate—obesity	3.52e-05	0.000293	CcSEcCtD
Nefazodone—Somnolence—Topiramate—obesity	3.51e-05	0.000292	CcSEcCtD
Nefazodone—Dyspepsia—Topiramate—obesity	3.47e-05	0.000289	CcSEcCtD
Nefazodone—Decreased appetite—Topiramate—obesity	3.43e-05	0.000286	CcSEcCtD
Nefazodone—Constipation—Topiramate—obesity	3.37e-05	0.000281	CcSEcCtD
Nefazodone—Pain—Topiramate—obesity	3.37e-05	0.000281	CcSEcCtD
Nefazodone—Thioproperazine—ALB—obesity	3.29e-05	0.0117	CrCbGaD
Nefazodone—Trifluoperazine—HTR2A—obesity	3.27e-05	0.0117	CrCbGaD
Nefazodone—Feeling abnormal—Topiramate—obesity	3.25e-05	0.000271	CcSEcCtD
Nefazodone—Perphenazine—HTR2A—obesity	3.23e-05	0.0115	CrCbGaD
Nefazodone—Gastrointestinal pain—Topiramate—obesity	3.23e-05	0.000269	CcSEcCtD
Nefazodone—Quetiapine—HTR2A—obesity	3.17e-05	0.0113	CrCbGaD
Nefazodone—Urticaria—Topiramate—obesity	3.13e-05	0.000261	CcSEcCtD
Nefazodone—Abdominal pain—Topiramate—obesity	3.12e-05	0.00026	CcSEcCtD
Nefazodone—Body temperature increased—Topiramate—obesity	3.12e-05	0.00026	CcSEcCtD
Nefazodone—Hypersensitivity—Topiramate—obesity	2.91e-05	0.000242	CcSEcCtD
Nefazodone—Asthenia—Topiramate—obesity	2.83e-05	0.000236	CcSEcCtD
Nefazodone—Pruritus—Topiramate—obesity	2.79e-05	0.000232	CcSEcCtD
Nefazodone—Diarrhoea—Topiramate—obesity	2.7e-05	0.000225	CcSEcCtD
Nefazodone—Dizziness—Topiramate—obesity	2.61e-05	0.000217	CcSEcCtD
Nefazodone—Vomiting—Topiramate—obesity	2.51e-05	0.000209	CcSEcCtD
Nefazodone—Rash—Topiramate—obesity	2.49e-05	0.000207	CcSEcCtD
Nefazodone—Dermatitis—Topiramate—obesity	2.48e-05	0.000207	CcSEcCtD
Nefazodone—Headache—Topiramate—obesity	2.47e-05	0.000206	CcSEcCtD
Nefazodone—Nausea—Topiramate—obesity	2.34e-05	0.000195	CcSEcCtD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.55e-06	2.13e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TYK2—obesity	1.55e-06	2.13e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TYK2—obesity	1.54e-06	2.12e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RHOA—obesity	1.54e-06	2.12e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GPX1—obesity	1.54e-06	2.11e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3CD—obesity	1.53e-06	2.11e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CETP—obesity	1.53e-06	2.11e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IRS1—obesity	1.53e-06	2.11e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RHOA—obesity	1.53e-06	2.1e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ESR1—obesity	1.52e-06	2.1e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARG—obesity	1.52e-06	2.1e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PIK3R1—obesity	1.52e-06	2.09e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—obesity	1.52e-06	2.09e-05	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	1.52e-06	2.09e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SERPINE1—obesity	1.52e-06	2.09e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SDC1—obesity	1.52e-06	2.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3CD—obesity	1.51e-06	2.08e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PIK3R1—obesity	1.51e-06	2.08e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—obesity	1.51e-06	2.08e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—obesity	1.51e-06	2.07e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—F2—obesity	1.5e-06	2.07e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRKCB—obesity	1.5e-06	2.07e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—obesity	1.5e-06	2.07e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—INS—obesity	1.5e-06	2.06e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CD36—obesity	1.5e-06	2.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—obesity	1.49e-06	2.06e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—INS—obesity	1.49e-06	2.06e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKR1C3—obesity	1.49e-06	2.05e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—BAD—obesity	1.49e-06	2.05e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LPL—obesity	1.48e-06	2.04e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TYK2—obesity	1.48e-06	2.03e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—obesity	1.48e-06	2.03e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—obesity	1.47e-06	2.03e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SCARB1—obesity	1.47e-06	2.02e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—INS—obesity	1.47e-06	2.02e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RHOA—obesity	1.46e-06	2.01e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF1—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—PIK3CA—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3R1—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AKT2—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GPX1—obesity	1.45e-06	1.99e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—obesity	1.44e-06	1.99e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—PIK3CA—obesity	1.44e-06	1.98e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.44e-06	1.98e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—obesity	1.43e-06	1.97e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3R1—obesity	1.43e-06	1.97e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SREBF1—obesity	1.43e-06	1.96e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IRS1—obesity	1.42e-06	1.96e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF1—obesity	1.42e-06	1.95e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AKT2—obesity	1.42e-06	1.95e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—obesity	1.42e-06	1.95e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CD36—obesity	1.41e-06	1.94e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MTOR—obesity	1.4e-06	1.93e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PIK3CB—obesity	1.4e-06	1.93e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PIK3CB—obesity	1.4e-06	1.92e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MTOR—obesity	1.4e-06	1.92e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3CD—obesity	1.39e-06	1.92e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARA—obesity	1.39e-06	1.91e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3CD—obesity	1.39e-06	1.91e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT2—obesity	1.39e-06	1.91e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—PIK3CA—obesity	1.38e-06	1.9e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.38e-06	1.9e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SERPINE1—obesity	1.38e-06	1.89e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—obesity	1.37e-06	1.89e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—obesity	1.37e-06	1.88e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—INS—obesity	1.36e-06	1.88e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.36e-06	1.88e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—FASN—obesity	1.36e-06	1.87e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—BCHE—obesity	1.35e-06	1.86e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.35e-06	1.86e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.35e-06	1.85e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AGT—obesity	1.35e-06	1.85e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—obesity	1.34e-06	1.85e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TYK2—obesity	1.34e-06	1.84e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MTOR—obesity	1.34e-06	1.84e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.34e-06	1.84e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—obesity	1.34e-06	1.84e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RHOA—obesity	1.33e-06	1.83e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3CB—obesity	1.32e-06	1.82e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOE—obesity	1.32e-06	1.82e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF1—obesity	1.32e-06	1.81e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT2—obesity	1.32e-06	1.81e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—obesity	1.31e-06	1.81e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3R1—obesity	1.31e-06	1.81e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TYK2—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARA—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3R1—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAV1—obesity	1.31e-06	1.8e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOA1—obesity	1.3e-06	1.8e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2E1—obesity	1.3e-06	1.79e-05	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—AKT1—obesity	1.3e-06	1.79e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RHOA—obesity	1.3e-06	1.79e-05	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—AKT1—obesity	1.3e-06	1.78e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NQO1—obesity	1.29e-06	1.77e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—obesity	1.29e-06	1.77e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.29e-06	1.77e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—obesity	1.28e-06	1.77e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—obesity	1.28e-06	1.76e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AGT—obesity	1.27e-06	1.75e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.27e-06	1.74e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.25e-06	1.73e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.25e-06	1.72e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.25e-06	1.72e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOE—obesity	1.24e-06	1.71e-05	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—AKT1—obesity	1.24e-06	1.71e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCG—obesity	1.24e-06	1.7e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SLC2A4—obesity	1.24e-06	1.7e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAV1—obesity	1.23e-06	1.7e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOA1—obesity	1.23e-06	1.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.23e-06	1.69e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—obesity	1.22e-06	1.68e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—obesity	1.22e-06	1.68e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYCS—obesity	1.22e-06	1.68e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TYK2—obesity	1.22e-06	1.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—obesity	1.21e-06	1.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MTOR—obesity	1.21e-06	1.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3CB—obesity	1.21e-06	1.67e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3CB—obesity	1.21e-06	1.66e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RHOA—obesity	1.21e-06	1.66e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—obesity	1.2e-06	1.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT1—obesity	1.2e-06	1.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT1—obesity	1.2e-06	1.65e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.2e-06	1.65e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—obesity	1.2e-06	1.65e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CG—obesity	1.19e-06	1.64e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CB—obesity	1.19e-06	1.63e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MTOR—obesity	1.19e-06	1.63e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MAPK8—obesity	1.19e-06	1.63e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—AKT1—obesity	1.18e-06	1.63e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MAPK8—obesity	1.18e-06	1.62e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NCOA1—obesity	1.18e-06	1.62e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—AKT1—obesity	1.18e-06	1.62e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—obesity	1.16e-06	1.6e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP19A1—obesity	1.16e-06	1.6e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—STK11—obesity	1.16e-06	1.6e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARG—obesity	1.15e-06	1.58e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.14e-06	1.57e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—obesity	1.13e-06	1.56e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MAPK8—obesity	1.13e-06	1.56e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—INS—obesity	1.13e-06	1.55e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—AKT1—obesity	1.13e-06	1.55e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—AKT1—obesity	1.13e-06	1.55e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CG—obesity	1.12e-06	1.54e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—obesity	1.11e-06	1.53e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MTOR—obesity	1.1e-06	1.52e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.1e-06	1.52e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—AKT1—obesity	1.1e-06	1.52e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—obesity	1.09e-06	1.49e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT3—obesity	1.08e-06	1.49e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARG—obesity	1.08e-06	1.49e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—COMT—obesity	1.08e-06	1.49e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT3—obesity	1.08e-06	1.49e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—obesity	1.07e-06	1.47e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GNB3—obesity	1.07e-06	1.47e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARGC1A—obesity	1.07e-06	1.47e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—INS—obesity	1.06e-06	1.46e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HMOX1—obesity	1.06e-06	1.46e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—obesity	1.05e-06	1.45e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CD—obesity	1.05e-06	1.44e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GNAS—obesity	1.04e-06	1.43e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—obesity	1.03e-06	1.42e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT3—obesity	1.03e-06	1.42e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—obesity	1.03e-06	1.42e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MAPK8—obesity	1.03e-06	1.41e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.02e-06	1.41e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—AKT1—obesity	1.02e-06	1.41e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PIK3CA—obesity	1.02e-06	1.4e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOB—obesity	1.02e-06	1.4e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—obesity	1.01e-06	1.39e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MYC—obesity	1.01e-06	1.39e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—obesity	1.01e-06	1.38e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MAPK8—obesity	1e-06	1.38e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MYC—obesity	1e-06	1.38e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—AKT1—obesity	1e-06	1.38e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—obesity	1e-06	1.38e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3R1—obesity	9.89e-07	1.36e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—obesity	9.89e-07	1.36e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CD—obesity	9.86e-07	1.36e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—obesity	9.74e-07	1.34e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPL—obesity	9.7e-07	1.33e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MYC—obesity	9.6e-07	1.32e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—obesity	9.59e-07	1.32e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—obesity	9.58e-07	1.32e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GPX1—obesity	9.46e-07	1.3e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT3—obesity	9.37e-07	1.29e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MAPK8—obesity	9.33e-07	1.28e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3R1—obesity	9.32e-07	1.28e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—obesity	9.32e-07	1.28e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—AKT1—obesity	9.3e-07	1.28e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CD36—obesity	9.21e-07	1.27e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT3—obesity	9.18e-07	1.26e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CB—obesity	9.12e-07	1.26e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—obesity	9.04e-07	1.24e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—obesity	8.73e-07	1.2e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MYC—obesity	8.71e-07	1.2e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—obesity	8.69e-07	1.2e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CB—obesity	8.6e-07	1.18e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARA—obesity	8.57e-07	1.18e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PIK3CA—obesity	8.56e-07	1.18e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MYC—obesity	8.53e-07	1.17e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT3—obesity	8.53e-07	1.17e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—obesity	8.52e-07	1.17e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PIK3CA—obesity	8.51e-07	1.17e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—obesity	8.51e-07	1.17e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AKT1—obesity	8.33e-07	1.15e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AGT—obesity	8.3e-07	1.14e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3CA—obesity	8.15e-07	1.12e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOE—obesity	8.13e-07	1.12e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAV1—obesity	8.05e-07	1.11e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3CA—obesity	8.04e-07	1.11e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOA1—obesity	8.04e-07	1.11e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MYC—obesity	7.92e-07	1.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—obesity	7.9e-07	1.09e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—obesity	7.58e-07	1.04e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—obesity	7.54e-07	1.04e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3CA—obesity	7.39e-07	1.02e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3CA—obesity	7.37e-07	1.01e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CG—obesity	7.34e-07	1.01e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CA—obesity	7.24e-07	9.96e-06	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—obesity	7.22e-07	9.93e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARG—obesity	7.08e-07	9.75e-06	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AKT1—obesity	6.99e-07	9.62e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—obesity	6.98e-07	9.61e-06	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AKT1—obesity	6.96e-07	9.57e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—INS—obesity	6.94e-07	9.56e-06	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CA—obesity	6.73e-07	9.26e-06	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AKT1—obesity	6.66e-07	9.16e-06	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AKT1—obesity	6.57e-07	9.04e-06	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—obesity	6.55e-07	9.01e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CD—obesity	6.45e-07	8.88e-06	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—obesity	6.41e-07	8.82e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—obesity	6.37e-07	8.76e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—obesity	6.09e-07	8.38e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3R1—obesity	6.09e-07	8.38e-06	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AKT1—obesity	6.04e-07	8.31e-06	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AKT1—obesity	6.02e-07	8.29e-06	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—obesity	5.96e-07	8.2e-06	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AKT1—obesity	5.91e-07	8.14e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CB—obesity	5.62e-07	7.74e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—obesity	5.57e-07	7.67e-06	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CA—obesity	5.56e-07	7.66e-06	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT1—obesity	5.49e-07	7.56e-06	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CA—obesity	5.24e-07	7.21e-06	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AKT1—obesity	4.54e-07	6.25e-06	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AKT1—obesity	4.28e-07	5.89e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CA—obesity	3.43e-07	4.72e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKT1—obesity	2.8e-07	3.85e-06	CbGpPWpGaD
